An investigation on behalf of investors in Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) shares over potential wrongdoing at Oramed Pharmaceuticals was announced and NASDAQ:ORMP stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 06/12/2017 --An investigation was announced for investors in shares of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) was announced over potential breaches of fiduciary duties by certain directors at Oramed Pharmaceuticals.

Investors who purchased shares of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Oramed Pharmaceuticals, Inc. officers and directors breached their fiduciary duties.

Israel based Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed Pharmaceuticals, Inc. reported that its Net Loss increased from $7.23 million for the 12 months period that ended on August 31, 2015 to $10.96 million for the 12 months period that ended on August 31, 2016. Shares of Oramed Pharmaceuticals, Inc. closed on June 9, 2017at $7.77 per share.

Those who purchased shares of Oramed Pharmaceuticals, Inc. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com